1. Home
  2. FRSH vs IDYA Comparison

FRSH vs IDYA Comparison

Compare FRSH & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Freshworks Inc.

FRSH

Freshworks Inc.

HOLD

Current Price

$11.50

Market Cap

3.3B

Sector

Technology

ML Signal

HOLD

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$37.02

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRSH
IDYA
Founded
2010
2015
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
2.9B
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
FRSH
IDYA
Price
$11.50
$37.02
Analyst Decision
Buy
Strong Buy
Analyst Count
16
14
Target Price
$19.53
$49.33
AVG Volume (30 Days)
3.3M
937.5K
Earning Date
02-10-2026
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$810,640,000.00
$214,834,000.00
Revenue This Year
$18.20
$2,662.86
Revenue Next Year
$13.27
N/A
P/E Ratio
N/A
N/A
Revenue Growth
18.18
5377.66
52 Week Low
$10.51
$13.45
52 Week High
$19.77
$39.28

Technical Indicators

Market Signals
Indicator
FRSH
IDYA
Relative Strength Index (RSI) 39.11 57.51
Support Level $11.52 $35.94
Resistance Level $12.36 $38.03
Average True Range (ATR) 0.34 1.61
MACD -0.07 0.06
Stochastic Oscillator 5.50 65.02

Price Performance

Historical Comparison
FRSH
IDYA

About FRSH Freshworks Inc.

Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks. It offers solutions that serve the needs of users in the CS and ITSM categories and has also expanded its offering with Sales and Marketing automation products. These product offerings enable organizations to acquire, engage, and serve their customers and employees. The group derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and Other regions.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: